Claim Ledger
42% answered
Did management answer the analysts?
12 analyst questions audited, 4 evaded or deflected.
View Claim Ledger →Bajaj Finserv — Q2 FY25
Bajaj Finserv reported consolidated revenue growth of 30% YoY to ₹33,703 crore, with PAT up 8% YoY.
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Bajaj Finserv reported consolidated revenue growth of 30% YoY to ₹33,703 crore, with PAT up 8% YoY. The general insurance business (BAGIC) saw core premium growth of 11% (3x market), though headline GWP fell 20% due to a government health shift to Q3. Combined ratio worsened to 101.4% from 95.3% due to higher natural catastrophe claims. Life insurance (BALIC) grew individual retail new business by 34% YoY, but VNB margins declined 3.8pp to 9.2% due to a mix shift toward ULIPs. Bajaj Finance AUM grew 29% with strong asset quality (GNPA 1.06%). Management highlighted disciplined underwriting and risk management, but flagged near-term headwinds from regulatory changes (surrender value norms) and competitive pressure in credit life. Key risk: further margin compression in life insurance if ULIP dominance persists.
बजाज फिनसर्व का कुल राजस्व पिछले साल की तुलना में 30% बढ़कर ₹33,703 करोड़ हो गया, और मुनाफा 8% बढ़ा। उनकी जनरल इंश्योरेंस कंपनी (BAGIC) का मुख्य प्रीमियम 11% बढ़ा, जो बाजार से तीन गुना ज्यादा है, लेकिन सरकारी स्वास्थ्य योजना के तीसरी तिमाही में शिफ्ट होने से कुल प्रीमियम 20% गिर गया। प्राकृतिक आपदाओं के दावों के कारण कंपनी का खर्च-आय अनुपात बिगड़कर 101.4% हो गया। लाइफ इंश्योरेंस (BALIC) में व्यक्तिगत नए कारोबार में 34% वृद्धि हुई, लेकिन ULIPs की बढ़ती हिस्सेदारी से मुनाफा मार्जिन 9.2% पर आ गया। बजाज फाइनेंस के कुल ऋण में 29% वृद्धि हुई और खराब कर्ज सिर्फ 1.06% रहा। प्रबंधन ने सतर्कता बरतने की बात कही, लेकिन नियामक बदलावों और प्रतिस्पर्धा से चुनौतियों का संकेत दिया। मुख्य जोखिम: लाइफ इंश्योरेंस में ULIPs के बढ़ने से मार्जिन और कम हो सकता है।
Promises0 met · 2 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Promises
2 promises
Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →
Risks
4 risks
Risk Intelligence
Allianz exit from JV creates strategic uncertainty
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Core GWP Growth (ex-crop & govt health)
11%
+7pp YoY
BAGIC's core business grew 11% vs industry 4%, driven by disciplined underwriting.
Individual Retail APE Growth
34%
+34% YoY
BALIC's individual retail new business grew 34% YoY, outpacing industry.
VNB Margin
9.2%
-3.8pp YoY
VNB margin fell to 9.2% due to higher ULIP mix; management expects recovery in H2.
Combined Ratio (BAGIC)
101.4%
+6.1pp YoY
Combined ratio worsened to 101.4% due to higher nat cat claims; ex-nat cat it was 99.7%.
What Changed vs Last Quarter
NEW
BALIC VNB margin improvement in H2
Management expects VNB margins to improve in H2 as product mix rebalances away from ULIPs and commission deferrals take effect.
NEW
Bajaj Finserv Direct breakeven in 1-2 quarters
The marketplace business expects to break even on a cash basis within the next couple of quarters.
NEW
Capital deployment of ₹500-600 crore in health & AMC by Mar'26
BFL plans to invest ₹500-600 crore in health tech and asset management over the next 18 months.
NEW
BAGIC core growth to remain above market
Management expects core premium growth to continue outpacing the industry, driven by disciplined underwriting.
DROPPED
BAGIC expects combined ratio to normalize in subsequent quarters
Management indicated that large commercial claims in Q1 are one-offs and not expected to recur, with combined ratio likely improving.
DROPPED
BALIC margins may see a pause in expansion this year due to surrender regulations
New surrender value norms could temporarily impact margin expansion, but medium-term expansion expected through product filings and cost optimization.
DROPPED
BFL expects collection efficiency to improve in H2
Steps taken to strengthen collections and slow rural B2C business should yield results in the second half of FY25.
DROPPED
Bajaj Finserv Health to provide long-term plan in 6-9 months
Post-Vidal acquisition, management will outline a complete long-range plan including breakeven visibility within 6-9 months.
NEW RISK
Allianz exit from JV creates strategic uncertainty
Allianz has informed Bajaj of its decision to exit the joint venture; management provided no further details, creating uncertainty around future ownership and operations.
NEW RISK
VNB margin compression from ULIP mix and regulatory changes
VNB margins fell 3.8pp YoY to 9.2% due to higher ULIP sales; new surrender value norms may further pressure margins.
NEW RISK
Motor TP price hike delay hurting growth
No TP price hike for three years has led to underwriting losses; management has reduced exposure, capping motor growth.
NEW RISK
Retail health profitability under pressure
Medical inflation and hospital fraud are squeezing margins; management is cautious on growth in this segment.
RISK GONE
Elevated loan losses and collection efficiency in BFL
BFL's loan losses and provisions were elevated in Q1 due to muted collection efficiencies and increase in stage 2 assets by INR 864 crore.
RISK GONE
Impact of new surrender regulations on BALIC margins
New IRDA surrender value norms may temporarily slow margin expansion; management was evasive on quantifying the impact.
RISK GONE
Large commercial claims in BAGIC may recur
Though termed one-offs, large property and liability claims caused combined ratio deterioration; similar claims could arise in future.
RISK GONE
Vidal acquisition may lead to customer attrition
Insurance partners of Vidal may withdraw business due to conflict of interest with Bajaj Finserv's insurance arms.
🤫 Topics management stopped discussing
Mentioned in Q3 FY24, Q4 FY24
Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.
Mentioned in Q1 FY24, Q2 FY24
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Mentioned in Q1 FY24, Q2 FY24
Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
Mentioned in Q2 FY24, Q4 FY24
Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.
Mentioned in Q3 FY24, Q4 FY24
Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.
Fast read
Guidance and risk preview
Management expects VNB margins to improve in H2 as product mix rebalances away from ULIPs and commission deferrals take effect.
Allianz has informed Bajaj of its decision to exit the joint venture; management provided no further details, creating uncertainty around future ow...
View Risks →